WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Discover www.zeiss.de/functionality
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumann, M. H.
Right arrow Articles by Rothman, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumann, M. H.
Right arrow Articles by Rothman, R. B.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 1998, 18(21):9069-9077

Functional Consequences of Central Serotonin Depletion Produced by Repeated Fenfluramine Administration in Rats

Michael H. Baumann, Mario A. Ayestas, and Richard B. Rothman

Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224

Repeated administration of D,L-fenfluramine (FEN) is known to cause prolonged depletion of forebrain serotonin (5-HT) in animals. Ironically, few studies have evaluated functional consequences of such FEN-induced 5-HT loss. In the present work, we examined neuroendocrine and behavioral responses evoked by acute FEN injection in rats that had previously received a 4 d FEN-dosing regimen known to deplete forebrain 5-HT (D,L-FEN, 20 mg/kg, s.c., b.i.d.). Rats were fitted with indwelling jugular catheters before the study to allow for repeated intravenous challenge injections and stress-free blood sampling. At 1 and 2 weeks after the 4 d dosing regimen, acute FEN (1.5 or 3.0 mg/kg, i.v.) produced dose-related elevations in plasma corticosterone and prolactin; these hormonal responses were markedly attenuated in FEN-pretreated rats. Behavioral effects of acute FEN, namely flat body posture and forepaw treading, were also blunted in FEN-pretreated rats. Interestingly, rats exposed to repeated FEN did not display overt abnormalities in hormonal or behavioral parameters under basal (i.e., unprovoked) conditions, despite dramatic decreases in postmortem tissue levels of 5-HT in numerous brain areas. Our results suggest that FEN-induced 5-HT depletion is accompanied by multiple impairments in 5-HT function. Although the clinical relevance of our data are debatable, the findings clearly show the utility of the FEN challenge test for uncovering in vivo functional deficits that might otherwise go undetected. FEN should remain an important pharmacological tool for determining the role of 5-HT neurons in mediating diverse physiological and behavioral processes.

Key words: fenfluramine; serotonin depletion; neuroendocrine; corticosterone; prolactin; behavior; neurotoxicity; serotonin function; rat

Copyright © 1998 Society for Neuroscience  0270-6474/98/18219069-09$05.00/0


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
X. Wang, M. H. Baumann, H. Xu, M. Morales, and R. B. Rothman
({+/-})-3,4-Methylenedioxymethamphetamine Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter Its Distribution between Endosomes and the Plasma Membrane
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1002 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
R. B. ROTHMAN, S. JAYANTHI, J. L. CADET, X. WANG, C. M. DERSCH, and M. H. BAUMANN
Substituted Amphetamines That Produce Long-Term Serotonin Depletion in Rat Brain ("Neurotoxicity") Do Not Decrease Serotonin Transporter Protein Expression
Ann. N.Y. Acad. Sci., October 1, 2004; 1025(1): 151 - 161.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Q. Li, L. Ma, R. B. Innis, N. Seneca, M. Ichise, H. Huang, M. Laruelle, and D. L. Murphy
Pharmacological and Genetic Characterization of Two Selective Serotonin Transporter Ligands: 2-[2-(Dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-Amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 481 - 486.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. D. Stocker, M. F. Muldoon, and A. F. Sved
Blunted Fenfluramine-Evoked Prolactin Secretion in Hypertensive Rats
Hypertension, October 1, 2003; 42(4): 719 - 724.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. H. Baumann, R. B. Rothman, J. P. Pablo, and D. C. Mash
In Vivo Neurobiological Effects of Ibogaine and Its O-Desmethyl Metabolite, 12-Hydroxyibogamine (Noribogaine), in Rats
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 531 - 539.
[Abstract] [Full Text]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. H. BAUMANN, M. A. AYESTAS, C. M. DERSCH, J. S. PARTILLA, and R. B. ROTHMAN
Serotonin Transporters, Serotonin Release, and the Mechanism of Fenfluramine Neurotoxicity
Ann. N.Y. Acad. Sci., September 1, 2000; 914(1): 172 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. H. BAUMANN, J. P. PABLO, S. F. ALI, R. B. ROTHMAN, and D. C. MASH
Noribogaine (12-Hydroxyibogamine): A Biologically Active Metabolite of the Antiaddictive Drug Ibogaine
Ann. N.Y. Acad. Sci., September 1, 2000; 914(1): 354 - 368.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-